Guangdong Bozhou Pharmaceutical Co., Ltd.
-
Founded in:
2000-12-07 -
Country:
China -
Address:
Green Industrial Park, Jiedong Economic Development Zone, Jieyang City -
Tax NO.:
9144520372599310X7 -
Registered Funds:
20 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefpiramide sodium |
It has strong antibacterial activity against Gram-positive bacteria and also has broad-spectrum antibacterial activity against bacteria including Gram-negative bacteria; it has strong antibacterial activity against glucose non-fermenting Gram-negative bacteria such as Pseudomonas aeruginosa; it is stable to β-lactamases produced by various bacteria; it has a strong affinity with 1A, 1B and 3 of penicillin-binding protein (PBP), inhibiting the synthesis of bacterial cell walls and thus exerting a bactericidal effect.
More
It has strong antibacterial activity against Gram-positive bacteria and also has broad-spectrum antibacterial activity against bacteria including Gram-negative bacteria; it has strong antibacterial activity against glucose non-fermenting Gram-negative bacteria such as Pseudomonas aeruginosa; it is stable to β-lactamases produced by various bacteria; it has a strong affinity with 1A, 1B and 3 of penicillin-binding protein (PBP), inhibiting the synthesis of bacterial cell walls and thus exerting a bactericidal effect. |
74849-93-7 | 4 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefuroxime Sodium |
Cefuroxime Sodium for Injection kills bacteria by inhibiting bacterial cell wall synthesis, and due to the structural characteristics of this product, it has a high resistance to beta-lactamase produced by bacteria. The following common clinical Gram-positive, Gram-negative aerobic and anaerobic pathogens are highly sensitive to this product.
More
Cefuroxime Sodium for Injection kills bacteria by inhibiting bacterial cell wall synthesis, and due to the structural characteristics of this product, it has a high resistance to beta-lactamase produced by bacteria. The following common clinical Gram-positive, Gram-negative aerobic and anaerobic pathogens are highly sensitive to this product. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ceftezole sodium |
It exerts its antibacterial activity by inhibiting the synthesis of bacterial cell walls, and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus).
More
It exerts its antibacterial activity by inhibiting the synthesis of bacterial cell walls, and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus). |
41136-22-5 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefdinir |
It has a wide range of antibacterial spectrum against Gram-positive and Gram-negative bacteria, especially against Staphylococcus and Streptococcus among Gram-positive bacteria. Its mode of action is bactericidal, and it is stable against β-lactamase produced by various bacteria, and it also has excellent antibacterial activity against β-lactamase producing bacteria. The mechanism of action is to prevent the synthesis of bacterial cell walls, and it has a strong affinity for penicillin binding proteins (PBP) 1 (1a.lbs), 2, and 3, but the active sites for different bacteria are different.
More
It has a wide range of antibacterial spectrum against Gram-positive and Gram-negative bacteria, especially against Staphylococcus and Streptococcus among Gram-positive bacteria. Its mode of action is bactericidal, and it is stable against β-lactamase produced by various bacteria, and it also has excellent antibacterial activity against β-lactamase producing bacteria. The mechanism of action is to prevent the synthesis of bacterial cell walls, and it has a strong affinity for penicillin binding proteins (PBP) 1 (1a.lbs), 2, and 3, but the active sites for different bacteria are different. |
91832-40-5 | 20 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefdinir |
It has a wide range of antibacterial spectrum against Gram-positive and Gram-negative bacteria, especially against Staphylococcus and Streptococcus among Gram-positive bacteria, and its mode of action is bactericidal. It is stable against beta-lactamase produced by various bacteria, and also has excellent antibacterial activity against beta-lactamase producing bacteria. The mechanism of action is to prevent the synthesis of bacterial cell wall, and it has strong affinity for penicillin binding protein (PBP) 1 (1a.lbs), 2, 3, but the active sites for different bacteria are different.
More
It has a wide range of antibacterial spectrum against Gram-positive and Gram-negative bacteria, especially against Staphylococcus and Streptococcus among Gram-positive bacteria, and its mode of action is bactericidal. It is stable against beta-lactamase produced by various bacteria, and also has excellent antibacterial activity against beta-lactamase producing bacteria. The mechanism of action is to prevent the synthesis of bacterial cell wall, and it has strong affinity for penicillin binding protein (PBP) 1 (1a.lbs), 2, 3, but the active sites for different bacteria are different. |
91832-40-5 | 20 |